Last update 04 Nov 2024

Mixed Protamine Human Insulin Injection (30R)

Overview

Basic Info

Drug Type
Hormone
Synonyms
普秀霖
Target
INSR
Mechanism
INSR agonists(Insulin receptor agonists)
Therapeutic Areas
Immune System DiseasesEndocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Gan & Lee Pharmaceuticals Co., Ltd.Gan & Lee Pharmaceuticals Co., Ltd.
Active Organization
Gan & Lee Pharmaceuticals Co., Ltd.Gan & Lee Pharmaceuticals Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (19 May 2021),
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Mixed Protamine Human Insulin Injection (30R)
CTR20131068 / Active, not recruitingPhase 3
多中心、随机平行、开放试验比较本品（普秀霖30R）与诺和灵30R治疗2型糖尿病的有效性和安全性
[Translation] A multicenter, randomized, parallel, open trial comparing the efficacy and safety of this product (Puxiulin 30R) and Novolin 30R in the treatment of type 2 diabetes
CTR20131064 / Active, not recruitingPhase 3
多中心、随机平行、开放试验比较本品（普秀霖30R）与诺和灵30R治疗2型糖尿病的有效性和安全性
[Translation] A multicenter, randomized, parallel, open trial comparing the efficacy and safety of this product (Puxiulin 30R) and Novolin 30R in the treatment of type 2 diabetes
CTR20131067 / Active, not recruitingPhase 3
多中心、随机平行、开放试验比较本品（普秀霖30R）与诺和灵30R治疗2型糖尿病的有效性和安全性
[Translation] A multicenter, randomized, parallel, open trial comparing the efficacy and safety of this product (Puxiulin 30R) and Novolin 30R in the treatment of type 2 diabetes
100 Clinical Results associated with Mixed Protamine Human Insulin Injection (30R)
Login to view more data
100 Translational Medicine associated with Mixed Protamine Human Insulin Injection (30R)
Login to view more data
100 Patents (Medical) associated with Mixed Protamine Human Insulin Injection (30R)
Login to view more data
100 Deals associated with Mixed Protamine Human Insulin Injection (30R)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1
CN
Gan & Lee Pharmaceuticals Co., Ltd.Gan & Lee Pharmaceuticals Co., Ltd.
19 May 2021
Diabetes Mellitus, Type 2
CN
Gan & Lee Pharmaceuticals Co., Ltd.Gan & Lee Pharmaceuticals Co., Ltd.
19 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free